tiprankstipranks
Arovella Therapeutics Limited (AU:ALA)
ASX:ALA
Holding AU:ALA?
Track your performance easily

Arovella Therapeutics Limited (ALA) Financial Statements

10 Followers

Arovella Therapeutics Limited Financial Overview

Arovella Therapeutics Limited's market cap is currently ―. The company's EPS TTM is AU$-0.009; its P/E ratio is -19.35; Arovella Therapeutics Limited is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 6.07MAU$ 6.72MAU$ 977.47KAU$ 4.31MAU$ 98.13K
Total AssetsAU$ 9.21MAU$ 10.69MAU$ 6.71MAU$ 16.25MAU$ 16.64M
Total DebtAU$ 144.80KAU$ 79.23KAU$ 85.46KAU$ 53.12KAU$ 2.05M
Net DebtAU$ -5.93MAU$ -6.64MAU$ -892.01KAU$ -4.26MAU$ 1.95M
Total LiabilitiesAU$ 1.60MAU$ 1.71MAU$ 2.57MAU$ 2.28MAU$ 5.18M
Stockholders EquityAU$ 7.62MAU$ 8.98MAU$ 4.14MAU$ 13.98MAU$ 11.46M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Arovella Therapeutics Limited Earnings and Revenue History

Arovella Therapeutics Limited Debt to Assets

Arovella Therapeutics Limited Cash Flow

Arovella Therapeutics Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis